Micro Cfu Assay

Low-density distribution helps associate each visible colony with an individual progenitor cell or a limited starting cell population. This supports estimation of clonogenic potential because colony formation can be related to the cells initially placed in the supportive culture system. If cells are not sufficiently separated, distinguishing independent colonies becomes more difficult and may reduce the interpretability of the count.

Viability indicates whether cells remain alive, whereas colony formation reflects whether viable cells can also proliferate and produce a colony under the assay conditions. This functional distinction makes the Micro CFU assay useful when researchers need to evaluate cellular growth capacity rather than survival alone. The result can therefore reveal effects that a viability assessment may not capture.

Colony counts estimate the number of cells with colony-forming potential in the tested sample. Because individual progenitor cells proliferate and differentiate within the culture system, the result reflects a functional capacity rather than merely the presence of cellular material. Comparing counts across samples can help assess how disease states, drugs, or culture conditions influence progenitor-cell growth.

Drug exposure, disease state, and culture conditions can all alter the number of colonies produced or the functional activity represented by those colonies. The supportive culture environment is particularly important because it provides the setting for progenitor-cell proliferation and differentiation. Consequently, differences in assay results may indicate changes in cellular growth behavior under the tested conditions.

A typical workflow uses a small biological sample, distributes its cells at low density in a supportive culture system, allows individual progenitor cells to proliferate and differentiate, and then counts the visible colonies. The count is interpreted as an estimate of colony-forming potential. This sequence preserves the functional measurement while requiring less clinical material than a larger-format test.

The assay is valuable when investigators need to study hematopoietic stem and progenitor cells, monitor cell viability, or examine how drugs and disease states affect cellular growth. Its low sample requirement is advantageous when clinical material is limited. Researchers can also use it to evaluate the influence of culture conditions on colony formation and functional progenitor-cell activity.